Efficacy and Safety of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, for the Treatment of Keratoconjunctivitis Sicca: Pooled Analysis of a Phase 2b/3 and Phase 3 Study
Year: 2019
Type: article
Authors: John Sheppard, Shane Kannarr, Jodi Luchs, Ranjan Malhotra, Angela Justice, Abayomi Ogundele, Charles Darby, Jason Bacharach
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2966827320